Brandon Cooper retweeted
"And you know, Dr. Pitlick, your pharmacies and your network, they can do all of these pharmacies, specialty pharmacy services. It's nonsense that your local community pharmacist cannot provide you a better standard of care than a giant mail-order specialty pharmacy in the middle of nowhere. ⁓ so you see as you look at the like earnings calls that are coming out this quarter from the big PBMs, you see their PBM revenue actually going down, but their specialty pharmacy revenue is skyrocketing. It's going up higher than that. So the immediate win, I think, would be to break up pharmacies from the PBMs, but the longer term problem, because they're just going to shift it somewhere else. For biosimilars, they've set up their own pharmaceutical companies that white label for ⁓ the biosimilar so they can mark up the cost. They're gonna shift it somewhere else."
‼️My favorite of today's hearing!
THIS 💯This is the truth! It was never true that local pharmacies couldn't provide a better standard of care than specialty mail-order pharmacies in the middle of nowhere. That was just a trick for a pharmacy benefit managers to label medications as specialty medications then steer patients to their own pharmacies and distort the prices of those medications many times over the true cost. This is exactly what happened with my son when I looked to see how much insurance companies pharmacy benefit manager paid themselves over what they paid the local pharmacy for the two months we were allowed to use the local pharmacy.
Thank you @mcuban @alexosh
Brandon Cooper retweeted
CVS sees the writing on the wall: Americans want to break up the giant corporations dominating health care.
But this CEO is not fooling us—this lets CVS continue to own a massive conglomerate and rip people off.
We must break up these monopolies and put patients over profits.
The CEO of CVS says @SenWarren and @HawleyMO's Break Up Big Medicine bill is one of the reasons the company is breaking up! 👏
Brandon Cooper retweeted
That’s pretty funny. He is a genius financial engineer. The split is great for shareholders. Changes nothing for patients or anyone who pays for insurance or care.
He is posturing to be able to say “See, we broke up our company. “. Don’t fall for it @HawleyMO @SenWarren
We need to pass the bill now more than ever
CVS CEO David Joyner just said on CNBC that the Break Up Big Medicine legislation by @SenWarren and Josh Hawley (@HawleyMO) is one reason he is breaking up his company.
Brandon Cooper retweeted
Just ran a Medicare prescription drug plan comparison for patient who only takes 2 prescription medications:
Olmesartan 20mg, 90 tabs/90 days
Ezetimibe 10mg, 90 tabs/90 days
Price compared our independent pharmacy (a standard, in-network pharmacy) to 2 other standard, in-network pharmacies (Walmart and Genoa Healthcare) using @WellcarePlans network for 2027.
They are using @ExpressScripts as their PBM.
Here are the HUGE price discrepancies:
For #90 Olmesartan tablets:
Independent pharmacy gets $10.80
Walmart gets $60.30
Genoa Healthcare gets $566.10!!
- - - - - - - - - - - - - - - - - - - - -
For #90 Ezetimibe tablets:
Independent pharmacy gets $12.60
Walmart gets $60.30
Genoa Healthcare gets $926.10!!!
I’m pulling this data directly from Medicare.gov just in case anyone thinks I’m making this up.
I wish I were.
Do any one of these scumbag PBM CEOs still want to put out the false claim that independents are paid MORE?
Brandon Cooper retweeted
.@Sonderling47: “For years, previous administrations turned a blind eye as pharmacy middlemen built a fortress around their fees and compensation—but today, thanks to @POTUS, we ARE TEARING DOWN THAT FORTRESS—making the MOST SIGNIFICANT federal reforms for PBMs in decades.
We know this rule will bring down healthcare costs for Workers and Job Creators.”
This is exactly why we passed Act 624 in Arkansas to ban PBM-owned pharmacies from operating in our state. Paying one pharmacy more than another and then steering patients to that pharmacy ends up costing us all more in premiums and healthcare costs. Time for Congress to act!
Update on this.
There are some Medicare Part D plans in our area that are now going to “cover” Xarelto in 2027.
One of those options is @WellcarePlans , who utilizes @ExpressScripts as their pharmacy benefit manager.
I did a price comparison between a few different pharmacies in our area for 2027:
For context, right now a month supply (30 tablets) of Xarelto costs us $599 from our wholesaler.
Of the “preferred pharmacies”, here’s the list of how much they are paid:
CVS: $634.55
Walgreens: $644.35
Kroger: $661.10
Of the “standard, in-network pharmacies”, here’s the list of how much they are paid:
Walmart: $630.42
Genoa Healthcare (owned by @UnitedHealthGrp): $655.05
MY INDEPENDENT PHARMACY: $565.50
Hmm, our locally owned and operated pharmacy couldn’t even crack $600 from @ExpressScripts
Wonder why that is?
Maybe it’s because they want us all gone.
I reached out to them a while back about why there is such a large discrepancy in their “standard, in network” reimbursements across different pharmacies.
Their response?
“Your reimbursements are aligned with other similarly situated pharmacies”
Translation?
They continue to screw over independent pharmacies and pay bigger chains significantly more.
And they wonder why there is so much negativity towards PBMs…
1
1
61
Brandon Cooper retweeted
“We will see you…tomorrow night!”
15 years ago today, David Freese led an incredible comeback in Game 6 of the 2011 World Series!
Brandon Cooper retweeted
Ohio released it's report on #340B. Eye opening that Cleveland Clinic reported $272M (as in MILLION) in acquisition costs & $599M in payments for 340B drugs in-house. $22M costs & $70M in payments in 132 contract pharmacies. Can you say 340B profits?
odh.ohio.gov/know-our-progra…
Brandon Cooper retweeted
Insurers: “This will cause a rise in Premiums”.
Translation: “We aren’t making enough profits so we need to raise Premiums”
Brandon Cooper retweeted
Ted. Look at our deficit. Look at how much we pay in interest every minute of every day. Look what that is doing to interest rates.
It’s Econ 101, you either have to raise revenue significantly, cut spending, significantly. Or both.
Talarico committed to support the Break Up Big Medicine Bill. That was a pre requisite for my doing the event with him this week.
If this Hawley/ Warren bill passes, we would reduce the deficit. We would cut costs for patients. Drug pricing would drop like a rock.
Yet not a word from you in support Ted. Why ?
A true capitalist would understand how these economics work. They wouldn’t ignore the fact that our debt levels pull money away from business. And consumers.
If you truly want to do what is best for business, and the economy, we are going to have to raise taxes and cut spending.
The best place to cut spending is by removing the HealthCare middlemen that are Too Big To Care, which is exactly what the Break Up Big Medicine Bill does
You ready to whip up support among republicans ? Or do you prefer people dying because they can’t afford care , and the economy continuing to slow down because we are having to print money to financial engineer our debt obligations.
What say you Ted ?
Mark, your second paragraph refutes your first, and your support for James Talarico makes the contradiction even stranger.
You’re right: taxes change behavior. That’s why President Trump cut them. After years of Obama-era stagnation, we rewarded work and investment. Before COVID, unemployment hit a 50-year low and poverty fell to the lowest rate ever recorded.
Last July, every Senate Democrat voted to let a $4 trillion tax increase hit Americans, the largest in history. Now Talarico wants higher taxes, calls capitalism an “oppressive system” to be dismantled, says “God is nonbinary,” says there are “six really common biological sexes,” and wants a “giant welcome mat” at our southern border.
If incentives matter, and they do, why on earth would Texas go backwards?
Brandon Cooper retweeted
.@mcuban You can thank me for starting this fight against the PBMs in Rutledge v. PCMA. We took them to the SCOTUS and won 8-0 to prove that states can protect patients and hold PBMs accountable. Arkansas has been a leader on this for over a decade and we won’t stop anytime soon.
Get em Arkansas !
The strongest development is Arkansas. On August 21, the state reported Rule 128 orders against 32 PBMs covering roughly 1,600 plans, multiple NADAC-related penalties, a pending Navitus court challenge over access to self-funded ERISA-plan data, and an on-site Express Scripts examination scheduled for September 7–18 because regulators say they need to reconcile inconsistencies in information supplied during the examination.
Let’s hope you publicly report what you find !
Brandon Cooper retweeted
Arkansas was the first state in the nation to take on PBMs - the prescription drug middlemen who raise prices.
Thanks @mcuban for recognizing our hard work!
Get em Arkansas !
The strongest development is Arkansas. On August 21, the state reported Rule 128 orders against 32 PBMs covering roughly 1,600 plans, multiple NADAC-related penalties, a pending Navitus court challenge over access to self-funded ERISA-plan data, and an on-site Express Scripts examination scheduled for September 7–18 because regulators say they need to reconcile inconsistencies in information supplied during the examination.
Let’s hope you publicly report what you find !
Brandon Cooper retweeted
Get em Arkansas !
The strongest development is Arkansas. On August 21, the state reported Rule 128 orders against 32 PBMs covering roughly 1,600 plans, multiple NADAC-related penalties, a pending Navitus court challenge over access to self-funded ERISA-plan data, and an on-site Express Scripts examination scheduled for September 7–18 because regulators say they need to reconcile inconsistencies in information supplied during the examination.
Let’s hope you publicly report what you find !
Brandon Cooper retweeted
Based on the Denver PBM contract Claude gave us the Red Flsg checklist that every self insured employer can start with
Brandon Cooper retweeted
The city of Denver makes it’s PBM contract available online. So I grabbed it and had Claude look at it and answer a simple question “Where are they getting ripped off”
Here is it’s response:
Denver is getting hit in six places, and the contract says so out loud. This is a self-funded City & County of Denver plan (4,051 employees / 8,554 participants, 1/1/2023–12/31/2025, $80M max) where the only stated pharmacy fee is… nothing. The medical admin fee is $45.13 PEPM. There is no PBM admin fee. That’s your first tell — the pharmacy program is priced entirely in the dark.
1. Spread pricing, written into the contract three separate times. Section A7 (Claims Processing): on mail, specialty and retail, United retains the difference between what it reimburses the network pharmacy and what Denver pays. It’s repeated in the General Conditions of the Pharmacy Financials exhibit and again in the Specialty Pharmacy Discount Guarantee conditions. So the AWP-discount guarantees describe what Denver pays — not what the pharmacy receives. The delta is Optum’s revenue, uncapped and unreported. For a public entity, that’s the whole ballgame. FTC found the Big 3 generated an estimated $1.4 billion of spread income on specialty generics alone.
2. Rebates: 100% retained, replaced with a fixed per-script number. Section A8: United keeps 100% of pharmacy rebates and pays Denver a fixed brand-script guarantee instead — $740.43 retail / $1,020.22 mail in 2023, rising to $885.02 / $1,105.10 by 2025. The contract then says explicitly that any rebates above the fixed amount are United’s to keep. Manufacturer rebate administration fees are folded into the guarantee, meaning they’re netted against what Denver was already owed rather than paid over. Denver has no idea what the actual rebate yield is, and no contractual right to find out.
3. The Rebate Credit clause is the biosimilar killer. If Denver moves to a biosimilar, an authorized alternative, or a lower-WAC brand, United gets credited toward its rebate guarantee for the manufacturer revenue it would have earned had Denver stayed on the high-rebate originator. Translation: United is financially indifferent to Denver buying the cheaper drug. Denver’s savings on ingredient cost get clawed back through the rebate math.
4. Your five clauses — all present, all in United’s favor. Specialty Drugs are defined as “Prescription Drugs available at United’s Specialty Pharmacy.” That’s a circular definition: whatever Optum stocks is specialty. Then: “United reserves the right to change the designation of a drug from specialty to non-specialty based on market conditions.” Then: specialty dispensed inside United’s specialty network is excluded from the retail and mail guarantees. Specialty dispensed outside it gets swept into the retail guarantee. Specialty rebates are “included in retail.” The specialty guarantee itself is 20.7% off AWP composite — and any specialty drug not on United’s list is guaranteed at only 14.0%. United controls the list. Every new high-cost launch defaults to the 14% bucket. And spread is retained on top of the discount either way.
5. Medical-benefit specialty has no guarantee at all. “Specialty drugs typically covered under the medical benefit (physician’s office, ambulatory, home infusion), and/or transitioned to the pharmacy benefit, are excluded from all guarantees.” That’s the buy-and-bill oncology and infusion book — the most expensive spend in the plan — with zero pricing accountability. On medical drug rebates Denver gets 80%, United keeps 20% plus float interest, and an unnamed subcontractor takes an undisclosed cut on top.
6. The lock-in clauses, which are the reason you can’t fix any of the above. Denver may not negotiate with any manufacturer for rebates or direct purchase — doing so forfeits earned-but-unpaid rebates. All pricing guarantees require United as exclusive mail provider. Terminating pharmacy services early means United keeps every pending and future rebate.
Brandon Cooper retweeted
Call your senator and ask them to support this. Unless of course you think healthcare and insurance in this country are perfect
Insurance companies’ ownership of pharmacies and hospitals is raising consumer costs, but economic competition can counter inflating expenses, according to bipartisan legislation from Sens. Josh Hawley, R-Missouri, and Elizabeth Warren, D-Massachusetts.
“We need more competition. We need protections for patients. We need better and cheaper health care,” Hawley told The Lion in an exclusive interview Thursday.
Hawley and Warren reintroduced The Patients Before Monopolies Act last week to counter the monopolized medical field, in step with their second bipartisan bill, The Break Up Big Medicine Act. The Patients Before Monopolies Act prohibits pharmacy benefit managers (PBMs), the middlemen between pharmacies and insurance companies, from owning pharmacies and hospitals, Hawley explained.
“What’s happening is more and more of these insurance companies are buying up everything,” Hawley told The Lion. “They’re buying up the pharmacies. They’re buying up the doctor’s offices. They’re buying up the hospitals.”
@HawleyMO
Read full story: bit.ly/4vglY42
Brandon Cooper retweeted
UnitedHealth just had the chance to save Texas Medicaid a ton of money.
Guess what they did instead.
Last month, a generic version of Farxiga hit the market. Here's the price difference:
→ Brand Farxiga: ~$600/month
→ The new generic: ~$20 for a 3-month supply
That's roughly $7,000 per patient, per year. Multiply that by the number of Texas Medicaid patients on this drug and you're looking at millions of dollars in savings on a single medication.
Texas Medicaid is still paying for the brand.
Why?
Because UnitedHealth doesn't want the cheap option. They get a massive fee from the manufacturer for every brand-name prescription. They get a kickback per fill. The expensive drug staying on the formulary is how they make money. The cheap generic showing up wipes that revenue out.
So here's where it gets fun.
Texas Medicaid uses a Drug Utilization Review Board to vet the formulary. They meet quarterly. They just met. This massive savings opportunity? Never came up.
That's not an accident. The list of drugs the board reviews is provided by OptumRx — the PBM owned by UnitedHealth Group.
The company that profits from the overpayment gets to decide what the board is allowed to look at.
Farxiga must have slipped their mind.
Meanwhile, Texas is stuck overpaying so the company they hired to control costs can pocket millions. That's the whole game.
We fired the PBMs. No contracts, no rebates, no kickbacks. Just real cash prices.
Brandon Cooper retweeted
👏 Tennessee @GovBillLee just signed the FAIR Rx Act into law.
“This legislation simply gives these health care giants a choice — you can be a PBM or you can be a pharmacy, but you can’t be both. The FAIR Rx Act provides structural change that strikes at the crux of that conflict,” says NCPA CEO @RPhDouglas. “We applaud the governor and legislators for their courage, withstanding tremendous pressure from the PBM-insurer lobby to pass this bill and defend Tennessee’s patients, taxpayers, and pharmacies.”
Congratulations to @TNPharmacists!
Read the full release: ncpa.org/newsroom/news-relea…
Brandon Cooper retweeted
Exciting movement on a bill that hasn’t gotten a whole lot of notice but I think is important. HR 7895 by Rep. Rick Allen prohibit PBMs from paying kickbacks to brokers, consultants, etc in exchange for directing employer health plan/insurance to the PBM.@Commpharmacy























